Therapeutic alpha-interferons protein: structure, production, and biosimilar. (Q30361968)

20 June 2017

title

Therapeutic alpha-interferons protein: structure, production, and biosimilar. (English)

1 reference

20 June 2017

author

Elrashdy Moustafa Redwan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

1 June 2020

Elrashdy Moustafa Redwan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Nawal Abd El-Baky

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

1 June 2020

publication date

1 January 2015

1 reference

Preparative Biochemistry and Biotechnology

20 June 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

1 June 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

1 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

109-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

Virus interference. I. The interferon

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Interferons of Mice and Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The structure of one of the eight or more distinct chromosomal genes for human interferon-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Interferons and their actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The IFN gamma receptor: a paradigm for cytokine receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Two distinct families of human and bovine interferon-alpha genes are coordinately expressed and encode functional polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Family of human alpha-interferon-like sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

A novel class of human type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Synthesis in E. coli of a polypeptide with human leukocyte interferon activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

At least three human type alpha interferons: structure of alpha 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The structure of eight distinct cloned human leukocyte interferon cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The interferons: biological effects, mechanisms of action, and use in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Animal-derived pharmaceutical proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Pegylation: a novel process for modifying pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The role of differential expression of human interferon--a genes in antiviral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Assignment of the disulphide bonds of leukocyte interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The three-dimensional high resolution structure of human interferon α-2a determined by heteronuclear NMR spectroscopy in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Synthesis of the human insulin gene: protein expression, scaling up and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Structural characterisation of N-linked and O-linked oligosaccharides derived from interferon-alpha2b and interferon-alpha14c produced by Sendai-virus-induced human peripheral blood leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Identification of nine interferon-α subtypes produced by Sendai virus-induced human peripheral blood leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The human interferons—From protein purification and sequence to cloning and expression in bacteria: Before, between, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Human leukocyte interferon produced by E. coli is biologically active

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Production of interferon-alpha in high cell density cultures of recombinant Escherichia coli and its single step purification from refolded inclusion body proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Expression, purification, and characterization of recombinant human consensus interferon-alpha in Escherichia coli under λP(L) promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Production characteristics of interferon-alpha using an L-arabinose promoter system in a high-cell-density culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Expression of human interferon-α8 synthetic gene under P(BAD) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Protein aggregation in recombinant bacteria: biological role of inclusion bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Preparative protein refolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Secretory expression in Escherichia coli and Bacillus subtilis of human interferon alpha genes directed by staphylokinase signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Cloning and expression in biologically active form of the gene for human interferon alpha 2 in Streptomyces lividans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Expression and aggregation of recombinant human consensus interferon-alpha mutant by Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Strategies to maximize expression of rightly processed human interferon alpha2b in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Production of human alpha-interferon in silkworm using a baculovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Cell-free synthesis of human interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The anti-cancer activity of human consensus interferon-alpha synthesized in cell-free system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Interferon-inducible antiviral effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Innate recognition of viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Porcine alpha interferon inhibit Japanese encephalitis virus replication by different ISGs in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Anti-viral effect of interferon-alpha on bovine viral diarrhea virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Divergent activities of interferon-alpha subtypes against intracellular hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

21 January 2018

Therapy of Hepatitis C

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Interferon-alpha in tumor immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Replication of hepatitis B and delta viruses: appearance of viral mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Long-term retreatment in chronic hepatitis C patients who were non-responders to an initial course of interferon-alpha 2b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Response to interferon-alpha of Egyptian patients infected with hepatitis C virus genotype 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Multiple effects of interferon on the replication of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The effects of a maintenance therapy with peg-interferon alpha-2a on liver fibrosis in HIV/HCV co-infected patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Structural and biologic characterization of pegylated recombinant IFN-alpha2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon alpha-2a (PEGASYS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Chronic hepatitis C virus patients with breakthroughs during interferon treatment can successfully be retreated with consensus interferon. The Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

The natural interferon-alpha producing cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Anti-interferon alpha treatment in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

IFN- Production by Plasmacytoid Dendritic Cells Stimulated with RNA-Containing Immune Complexes Is Promoted by NK Cells via MIP-1 and LFA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

Differences in Activity between α and β Type I Interferons Explored by Mutational Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10826068.2014.907175

10.1080/10826068.2014.907175

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24785737 AND SRC:MED&resulttype=core&format=json

1 June 2020

1 reference